» Articles » PMID: 3896739

Temocillin in the Treatment of Serious Gram-negative Infections

Overview
Journal Drugs
Specialty Pharmacology
Date 1985 Jan 1
PMID 3896739
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Temocillin was used to treat 32 patients with proven or suspected infection caused by aerobic Gram-negative bacteria. 25 of these patients were assessable on clinical and bacteriological grounds. All 25 were either cured or improved, although in 5 patients with urinary tract infection there was relapse of infection or reinfection following the cessation of therapy. Clinical improvement was usually rapid and no serious side effect was noted. Temocillin would thus appear to be an effective and safe agent for the treatment of bacterial infection caused by aerobic Gram-negative organisms.

Citing Articles

Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.

Lupia T, De Benedetto I, Stroffolini G, Di Bella S, Mornese Pinna S, Zerbato V Antibiotics (Basel). 2022; 11(4).

PMID: 35453244 PMC: 9032032. DOI: 10.3390/antibiotics11040493.


Penicillins. A current review of their clinical pharmacology and therapeutic use.

Nathwani D, Wood M Drugs. 1993; 45(6):866-894.

PMID: 7691496 DOI: 10.2165/00003495-199345060-00002.

References
1.
Slocombe B, Basker M, BENTLEY P, Clayton J, Cole M, Comber K . BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans. Antimicrob Agents Chemother. 1981; 20(1):38-46. PMC: 181629. DOI: 10.1128/AAC.20.1.38. View